Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,221 | -9,383 | -6,858 | -14 | 668,629 |
| Depreciation Amortization | 2,238 | 1,652 | 1,104 | 558 | 2,361 |
| Income taxes - deferred | N/A | -6,110 | -4,975 | -3,793 | N/A |
| Accounts receivable | -4,113 | -6,062 | -20,679 | -9,681 | N/A |
| Accounts payable and accrued liabilities | -334 | 542 | 3,091 | 3,470 | 496 |
| Other Working Capital | -68,684 | -60,646 | -65,865 | -59,177 | 57,382 |
| Other Operating Activity | 16,965 | 15,249 | 21,941 | 7,964 | -747,138 |
| Operating Cash Flow | $-65,149 | $-64,758 | $-72,241 | $-60,673 | $-18,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,727 | -1,509 | -815 | -389 | -204 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 675,000 |
| Investing Cash Flow | $-3,727 | $-1,509 | $-815 | $-389 | $674,796 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -409,724 | 10,426 | 8,258 | -412,082 | 41,794 |
| Common Stock Repurchased | N/A | -420,000 | -420,000 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -62 | 0 | 302 |
| Financing Cash Flow | $-409,724 | $-409,574 | $-411,804 | $-412,082 | $42,096 |
| Exchange Rate Effect | 1,372 | -322 | -31 | 90 | 149 |
| Beginning Cash Position | 714,594 | 714,594 | 714,594 | 714,594 | 15,823 |
| End Cash Position | 237,366 | 238,431 | 229,703 | 241,540 | 714,594 |
| Net Cash Flow | $-477,228 | $-476,163 | $-484,891 | $-473,054 | $698,771 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,149 | -64,758 | -72,241 | -60,673 | -18,270 |
| Capital Expenditure | -3,727 | -1,509 | -815 | -389 | -204 |
| Free Cash Flow | -68,876 | -66,267 | -73,056 | -61,062 | -18,474 |